DWQA Questions › Category: Coronavirus COVID-19Filter:AllOpenResolvedClosedUnansweredSort byViewsAnswersVotesIn a preliminary study of adult outpatients with symptomatic COVID-19, patients treated with fluvoxamine, compared with placebo, had a lower likelihood of clinical deterioration. There was clinical deterioration in 0 of 80 patients in the fluvoxamine group and in 6 of 72 patients in the placebo group (absolute difference, 8.7% [95% CI, 1.8%-16.4%] from survival analysis; log-rank P = .009). The fluvoxamine group had 1 serious adverse event and 11 other adverse events, whereas the placebo group had 6 serious adverse events and 12 other adverse events. Is this a worthwhile agent for COVID-19 management? How would it compare with hydroxychloroquine or ivermectin?ClosedNicola asked 4 years ago • Coronavirus COVID-19291 views0 answers0 votesAn osteopathic physician and frequent spokesperson on the Internet says there are at least 10 ways that the SARS-CoV-2 mRNA vaccines can cause serious side effects in human recipients. Is this the case, or an exaggeration? Why is she beating this drum?ClosedNicola asked 4 years ago • Coronavirus COVID-19499 views0 answers0 votesA viewer asks: “Can creator comment on the new Johnson & Johnson COVID vaccine? This one does not use mRNA tech.” How safe and effective is this vaccine? Is it better to use this approach for reasons of better safety in not using the mRNA technology of other vaccines?ClosedNicola asked 4 years ago • Coronavirus COVID-19563 views0 answers0 votesThere is a story circulating that COVID-19 vaccines truncate (disable by cutting short) cancer tumor suppressors, and destroy the human body’s ability to protect against cancer. Truncated tumor-suppressor proteins are similar to the DNA mutations that cause cancer cells to mutate and multiply uncontrollably, suggesting America may see cancer cases skyrocket over the next few years due to COVID vaccines. Is there any truth to this? Is there any likelihood of greater cancer appearing in those vaccinated with an mRNA vaccine technology?ClosedNicola asked 4 years ago • Coronavirus COVID-19483 views0 answers0 votesWill the combination of ingredients and recommended dose levels in the Immunity Pump Protocol by Dr. Glenn Rothfeld be effective in blocking or minimizing the consequences of COVID-19 infection?ClosedNicola asked 4 years ago • Coronavirus COVID-19394 views0 answers0 votesLianhua Qingwen Capsules (LQC), which are also used against seasonal influenza, have been part of China’s standard of care against COVID-19 since February 2020, and countries like Thailand and Laos have also embraced the product. LQC, composed of 13 herbs, is said to have “a curative effect in patients with mild symptoms and helps to relieve fever, cough and fatigue,” and may also “help prevent the disease from worsening.” Research shows patients who received LQC along with “usual treatment” had improved recovery rates compared to controls (91.5% versus 82.4%). They also recovered faster (seven versus 10 days). Are these data accurate and of practical significance for COVID-19 disease management?ClosedNicola asked 4 years ago • Coronavirus COVID-19349 views0 answers0 votesJinhua Qinggan—this remedy for mild and moderate COVID-19 symptoms consisting of 12 herbs, including licorice, mint, and honeysuckle, helps remove heat and detoxify the lungs. According to the State Council:4“A comparative experiment showed patients who took Jinhua Qinggan granule tested negative for coronavirus 2.5 days earlier than a group that did not take it. The group treated with the granule also took eight days to show improvement, while the other group took 10.3 days.” Are these data accurate and of practical significance for COVID-19 disease management?ClosedNicola asked 4 years ago • Coronavirus COVID-19308 views0 answers0 votesAre there more promising Traditional Chinese medicine approaches under study that will be forthcoming to help better control the pandemic?ClosedNicola asked 4 years ago • Coronavirus COVID-19343 views0 answers0 votesStudies by South African scientists of the AstraZeneca-Oxford vaccine against COVID-19 showed minimal efficacy in preventing mild and moderate cases of the new variant, which added to the mounting evidence that the B.1.351 variant makes current vaccines less effective. Is that truly the case, or are the milder cases actually patients who would have had very severe illness without having taken the vaccine, because the new mutant is being artificially introduced at much higher concentrations and is not really more infectious or lethal?ClosedNicola asked 4 years ago • Coronavirus COVID-19388 views0 answers0 votesA viewer asks: “The General Hospital in my home town in Mexico produces this Chlorine Dioxide Solution (CDS) for all their staff members and their families. They do not recommend, however, the use of the CDS along with aspirin because aspirin is an anticoagulant. Is there any truth to their claim?”ClosedNicola asked 4 years ago • Coronavirus COVID-19393 views0 answers0 votesA practitioner asks: “From March 2020 I began including as primary clients in my sessions all health care practitioners, doctors, researchers, and their public speakers. How helpful were my sessions in preventing harm done to my clients by the interlopers, and how effective were they in spreading real solutions to the ongoing pandemic?”ClosedNicola asked 4 years ago • Coronavirus COVID-19329 views0 answers0 votesA viewer writes that he has been feeling flu-like symptoms for 2 weeks: “…totally drained every day and almost unable to get anything done, feel major brain fog, can’t stay awake very long, some days I can’t eat. And I just seem to be in a standstill and not getting better or worse.” What is causing this and what can we do to help?ClosedNicola asked 4 years ago • Coronavirus COVID-19334 views0 answers0 votesDr. Mary Fowkes was instrumental in highlighting the findings that COVID-19 has many systemic effects, including abnormal hypercoagulation with occurrence of large pulmonary emboli and microemboli in many organs, including lungs, heart, liver and brain. You commented that this phenomenon is heightened in patents with recurring illness. Is it also commonly contributing to morbidity and mortality in those patients with a first exposure who progress to severe symptoms needing intensive care?ClosedNicola asked 4 years ago • Coronavirus COVID-19285 views0 answers0 votesA viewer asks: “Is the Mercenary Army Program busily spreading new “mutations” of the COVID-19 virus?”ClosedNicola asked 4 years ago • Coronavirus COVID-19838 views0 answers0 votesA viewer asks: “Where has the flu gone? Is this just a relabeling of the flu as COVID-19?”ClosedNicola asked 4 years ago • Coronavirus COVID-19444 views0 answers0 votes
Nicola